These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3202553)

  • 1. [Continuous ambulatory chemotherapy in cancer of the upper respiratory and digestive tract].
    Bassot V; Ménard M; Janot F; Fabre A; Brasnu D; Donnadieu S; Laccourreye H
    Ann Otolaryngol Chir Cervicofac; 1988; 105(6):403-7. PubMed ID: 3202553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early death after chemotherapy via central venous catheterization in tumors of the upper respiratory and digestive tracts].
    Ayadi A; Bassot V; Donnadieu S; Brasnu D; Laccourreye M
    Ann Otolaryngol Chir Cervicofac; 1989; 106(6):271-4. PubMed ID: 2479311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ambulatory and domiciliary cancer chemotherapy with forearm implant catheter system and low-dose CDDP + 5-FU therapy].
    Tsuji A; Morita S; Horimi T; Takasaki M; Takahashi I; Shirasaka T
    Gan To Kagaku Ryoho; 1999 Dec; 26 Suppl 2():326-32. PubMed ID: 10630242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Outpatient chemotherapy with continuous infusion of 5-fluorouracil (CI 5-FU) and intravenous bolus leucovorin (IVB LV) in advanced gastrointestinal cancer: the second report].
    Tsuji Y; Yoshihito H; Nakamura T; Watanabe Y; Nakayama N; Ohi M; Kawanishi J; Handa H; Honjo K; Uehara S
    Gan To Kagaku Ryoho; 1995 Dec; 22 Suppl 4():439-46. PubMed ID: 8849290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined chemotherapy with 5-FU and low dose CDDP for advanced or recurrent cancer of the digestive system and home anti-cancer chemotherapy].
    Ogura T; Hiramatsu Y; Araki H; Kojima Y; Nakagawa A; Nakagawa M; Kamiyama Y; Shirasaka T
    Gan To Kagaku Ryoho; 1995 Dec; 22 Suppl 4():433-8. PubMed ID: 8849289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study of ambulatory infusional delivery of a multidrug regimen: cisplatin, 5-fluorouracil and leucovorin (PFL) +/- etoposide.
    Lokich J; Anderson N; Moore C; Bern M; Coco F; Dow E; Zipoli T; Gonzalves L
    J Infus Chemother; 1996; 6(1):43-6. PubMed ID: 8748007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility study of ambulatory continuous infusion of 5-fluorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancer.
    Qin B; Kato K; Mitsugi K; Nakamura M; Tanaka R; Baba E; Ariyama H; Kuroiwa T; Harada M; Nakano S
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):114-9. PubMed ID: 16001177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trial of outpatient anti-cancer chemotherapy with infusion of 5-FU and cisplatin for advanced gastric and colorectal cancers].
    Suzuki H; Kanou Y; Ooshima H; Kawase J; Kudou J; Mizuno Y; Matsumoto S
    Gan To Kagaku Ryoho; 2005 Feb; 32(2):189-93. PubMed ID: 15751631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Outpatient chemotherapy with continuous intravenous infusion for patients with recurrent renal cell carcinoma or advanced prostate carcinoma].
    Otsuka A; Ono S; Hata M; Ota N
    Gan To Kagaku Ryoho; 1997 Dec; 24 Suppl 4():485-9. PubMed ID: 9429553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Outpatient chemotherapy with continuous infusion of 5-fluorouracil (CI 5-FU) and intravenous bolus leucovorin (IVB LV) in advanced gastrointestinal cancer].
    Tsuji Y; Nakamura T; Katagiri E; Kawanishi J; Handa H; Honjo K; Uehara S; Izumiyama S; Hirayama A; Sagawa T
    Gan To Kagaku Ryoho; 1994 Dec; 21 Suppl 4():419-25. PubMed ID: 7802444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy in squamous cell carcinoma of the esophagus using low dose continuous infusion 5-fluorouracil and cisplatin: results of a prospective study.
    Aroori S; Parshad R; Kapoor A; Gupta SD; Kumar A; Chattophadyay TK
    Indian J Cancer; 2004; 41(1):3-7. PubMed ID: 15105572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up.
    Morgan RJ; Braly P; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Najera L; Johnson D; Doroshow JH
    Gynecol Oncol; 2000 Jun; 77(3):433-8. PubMed ID: 10831355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
    Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
    Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence-dependence of cisplatin and 5-fluorouracil in advanced and recurrent gastric cancer.
    Koizumi W; Kurihara M; Hasegawa K; Chonan A; Kubo Y; Maekawa R; Iwasaki R; Sasai T; Fukuyama Y; Ishikawa K; Miyoshi K; Yasutake K; Hayakawa M
    Oncol Rep; 2004 Sep; 12(3):557-61. PubMed ID: 15289837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva.
    Eifel PJ; Morris M; Burke TW; Levenback C; Gershenson DM
    Gynecol Oncol; 1995 Oct; 59(1):51-6. PubMed ID: 7557615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Consideration of cancer home chemotherapy with cooperation between hospital and clinic].
    Muto Y; Takebuchi K; Watanabe M; Hasegawa K; Sakonji M; Matsukawa M; Kurihara M
    Gan To Kagaku Ryoho; 1999 Dec; 26 Suppl 2():263-6. PubMed ID: 10630229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic monitoring with dosage adjustment of 5 fluorouracil administered by continuous infusion].
    Wihlm J; Levêque D; Velten M; Klein T
    Bull Cancer; 1993 May; 80(5):439-45. PubMed ID: 8173197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.